Shidong Lv

548 total citations
25 papers, 386 citations indexed

About

Shidong Lv is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Shidong Lv has authored 25 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Shidong Lv's work include Epigenetics and DNA Methylation (9 papers), Prostate Cancer Treatment and Research (8 papers) and Cancer-related gene regulation (4 papers). Shidong Lv is often cited by papers focused on Epigenetics and DNA Methylation (9 papers), Prostate Cancer Treatment and Research (8 papers) and Cancer-related gene regulation (4 papers). Shidong Lv collaborates with scholars based in China, United States and Macao. Shidong Lv's co-authors include Hongyi Wang, Chengyong Lei, Qiang Wei, Yongtong Zhu, Wei Wang, Qiang Wei, Wenhua Huang, Shuqiang Liu, Zhongqiu Liu and Elaine Lai‐Han Leung and has published in prestigious journals such as Journal of Clinical Investigation, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Shidong Lv

24 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shidong Lv China 10 252 111 97 74 28 25 386
Irene Marchesi Italy 14 315 1.3× 74 0.7× 85 0.9× 107 1.4× 23 0.8× 23 452
Cheng Fang China 10 259 1.0× 69 0.6× 146 1.5× 60 0.8× 22 0.8× 22 408
Xianjun Zhu China 7 255 1.0× 77 0.7× 134 1.4× 85 1.1× 26 0.9× 13 396
Ohuod Hawsawi United States 8 217 0.9× 85 0.8× 132 1.4× 63 0.9× 12 0.4× 10 330
Shuping Xu United States 13 304 1.2× 79 0.7× 96 1.0× 105 1.4× 21 0.8× 18 467
Ziyi Zhao China 13 338 1.3× 73 0.7× 183 1.9× 77 1.0× 31 1.1× 50 505
Jinyuan Pan China 10 247 1.0× 45 0.4× 144 1.5× 100 1.4× 28 1.0× 12 421
Youxiang Ding China 12 248 1.0× 42 0.4× 82 0.8× 83 1.1× 25 0.9× 16 399
Yong Luo China 13 250 1.0× 73 0.7× 157 1.6× 82 1.1× 31 1.1× 31 398
Hui-Ju Lee Taiwan 8 248 1.0× 103 0.9× 142 1.5× 64 0.9× 22 0.8× 10 415

Countries citing papers authored by Shidong Lv

Since Specialization
Citations

This map shows the geographic impact of Shidong Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shidong Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shidong Lv more than expected).

Fields of papers citing papers by Shidong Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shidong Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shidong Lv. The network helps show where Shidong Lv may publish in the future.

Co-authorship network of co-authors of Shidong Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Shidong Lv. A scholar is included among the top collaborators of Shidong Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shidong Lv. Shidong Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Guang, Shidong Lv, Laura E. Pascal, & Zhou Wang. (2025). Regulation of glucocorticoid receptor nuclear localization in prostate cancer cells. Journal of Pharmacology and Experimental Therapeutics. 392(5). 103577–103577.
3.
Zhang, Jianqiang, et al.. (2024). Exploring the role of coagulation-related genes in renal cell carcinoma: Implications for tumor microenvironment and prognostic biomarkers. Computational Biology and Chemistry. 110. 108082–108082. 1 indexed citations
4.
Zhang, Yifan, et al.. (2023). Experimental analysis of bladder cancer-associated mutations in EP300 identifies EP300-R1627W as a driver mutation. Molecular Medicine. 29(1). 7–7. 5 indexed citations
5.
Zhang, Jianqiang, et al.. (2023). Histone methyltransferase KMT2D promotes prostate cancer progression through paracrine IL-6 signaling. Biochemical and Biophysical Research Communications. 655. 35–43. 11 indexed citations
6.
Lv, Shidong, Zeyu Wu, Yifan Zhang, et al.. (2022). Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer. Cell Death and Disease. 13(9). 754–754. 12 indexed citations
7.
Zhang, Yifan, et al.. (2022). Histone methyltransferase KMT2D mediated lipid metabolism via peroxisome proliferator-activated receptor gamma in prostate cancer. Translational Cancer Research. 11(8). 2607–2621. 3 indexed citations
8.
Zhang, Xuehua, et al.. (2022). Comparable survival benefits of partial ureterectomy to radical nephroureterectomy in non-metastatic ureter carcinoma: a population-matched study. International Urology and Nephrology. 55(3). 579–588. 5 indexed citations
9.
Zhang, Yifan, et al.. (2022). Tautomycin and enzalutamide combination yields synergistic effects on castration-resistant prostate cancer. Cell Death Discovery. 8(1). 471–471. 3 indexed citations
10.
Lv, Shidong, et al.. (2021). Long noncoding RNA GAS5 interacts and suppresses androgen receptor activity in prostate cancer cells. The Prostate. 81(12). 893–901. 7 indexed citations
11.
Zhang, Wenqiang, Ruiyu Liu, Lin Zhang, et al.. (2021). Downregulation of miR-335 exhibited an oncogenic effect via promoting KDM3A/YAP1 networks in clear cell renal cell carcinoma. Cancer Gene Therapy. 29(5). 573–584. 14 indexed citations
12.
Lv, Shidong, Qiong Song, Guang Chen, et al.. (2020). Regulation and targeting of androgen receptor nuclear localization in castration-resistant prostate cancer. Journal of Clinical Investigation. 131(4). 42 indexed citations
13.
Wang, Zhi, Laura E. Pascal, Uma Chandran, et al.. (2020). <p>ELL2 Is Required for the Growth and Survival of AR-Negative Prostate Cancer Cells</p>. Cancer Management and Research. Volume 12. 4411–4427. 9 indexed citations
14.
Wang, Ning, Yaodong Jiang, Shidong Lv, et al.. (2020). HOTAIR expands the population of prostatic cancer stem-like cells and causes Docetaxel resistance via activating STAT3 signaling. Aging. 12(13). 12771–12782. 20 indexed citations
15.
Wei, Qiang, Wenhua Huang, Shidong Lv, et al.. (2019). Integrative molecular characterization of Chinese prostate cancer specimens. Asian Journal of Andrology. 22(2). 162–162. 9 indexed citations
16.
Lv, Shidong, Wei Wang, Hongyi Wang, Yongtong Zhu, & Chengyong Lei. (2019). PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway. BMC Cancer. 19(1). 204–204. 75 indexed citations
17.
Zhang, Guanghai, et al.. (2018). Steroidal glycoalkaloids in potato foods as affected by cooking methods. International Journal of Food Properties. 21(1). 1875–1887. 19 indexed citations
18.
Lei, Chengyong, Shidong Lv, Hongyi Wang, et al.. (2018). Leukemia Inhibitory Factor Receptor Suppresses the Metastasis of Clear Cell Renal Cell Carcinoma Through Negative Regulation of the Yes-Associated Protein. DNA and Cell Biology. 37(8). 659–669. 19 indexed citations
19.
Lv, Shidong, Liyan Ji, Bin Chen, et al.. (2017). Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4. Oncogene. 37(10). 1354–1368. 90 indexed citations
20.
Lv, Shidong, et al.. (2016). [Small RNA interference-mediated ADP-ribosylation factor 6 silencing inhibits proliferation, migration and invasion of human prostate cancer PC-3 cells].. PubMed. 36(6). 735–43. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026